EPO mimetics (Antyra)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameEPO mimetics (Antyra)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsNerve Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAntyra Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAntyra Inc

Active IndicationsN/A

Inactive IndicationsNerve Degeneration

ATC CodeN/A